Revita Life Sciences

Sexual Diseases

Erectile dysfunction

ED is defined as the consistent or recurrent inability to attain or maintain an erection sufficient for satisfactory sexual performance.

ED risk factors include widespread diseases such as hypertension and obesity, but also medications such as β-blockers and anti-depressants, as well as major life-style factors like smoking and alcohol use cause ED.

Moreover, age is a risk factor; approximately one third of men in their forties report ED symptoms, 50% of the male population aged between 40 and 70 years will suffer from ED at some stage, with 10% of these affected severely

How It Is Done

Some of the techniques for investigation of ED are penile ultrasound, penile doppler sonography, angiography, cavernosography, MRI, penile hemodynamics and nerve impulse speed.

200 ml of fat is aspirated and processed in a closed system for stem cells isolation. 2 ml volume having at least 2-4 million stem cells per kg body weight is injected.

Therapy of ED also includes administration of PRP along with Laser activated adipose derived stem cells with dose of 0.5 million to 1 million per kg body weight.

  • Non-alcoholic fatty liver disease NAFLD
  • Chronic viral infections of the liver 
  • Chronic Alcoholism
  • Drug-induced liver damage etc.

What To Expect

  • Improved vascularization
  • Harder penis with lasting erections
  • Better sexual performance and pleasure
  • 70 % patients recover erectile function after ADRC injection with the ability to complete intercourse.
  • Maximum recovery occurs within 3 months, and this effect persisted for 24 months.
  • International Index of Erectile Function-5 (IIEF-5) and Erection Hardness Score (EHS) are used to assess erectile function inclusion before and after stem cell administration.